
|Videos|September 9, 2021
Exploring new biological treatments in posterior uveitis
Author(s)Modern Retina Staff
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.
Advertisement
Quan Dong Nguyen, MD, MSc, FARVO, FASRS, director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University School of Medicine, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: MCO-010 sustains vision gains in RP through 4 years
2
AAO 2026: BRUNELLO 1-year results for remigromig in DME
3
Clobetasol cuts post-cataract inflammation and pain in phase 3 trial
4
AAO 2026: Tinlarebant in Stargardt disease: Jacque Duncan, MD, on DRAGON results
5


















